Avid Bioservices
Avid Bioservices, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States, with significant operational facilities in California. Founded in 1981, the company has established itself as a leader in the development and manufacturing of monoclonal antibodies and other biologics, catering to the needs of biotechnology and pharmaceutical companies. Avid Bioservices offers a comprehensive range of services, including process development, cGMP manufacturing, and analytical testing, all tailored to support the unique requirements of its clients. The company is recognised for its commitment to quality and innovation, which has positioned it favourably in the competitive landscape of contract development and manufacturing organisations (CDMOs). With a strong track record of successful partnerships and a focus on customer satisfaction, Avid Bioservices continues to drive advancements in biomanufacturing.
DitchCarbon Score
How does Avid Bioservices's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Furniture Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Avid Bioservices's score of 23 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Avid Bioservices's reported carbon emissions
Avid Bioservices, headquartered in the United States, has made significant commitments towards achieving net-zero carbon emissions by 2050. Although specific emissions data for the most recent year is not available, the company has committed to reducing emissions across all scopes as part of its long-term climate strategy. Avid Bioservices is actively engaged in the Science Based Targets initiative (SBTi), demonstrating its commitment to climate action. The company has set a net-zero target, with a commitment to start implementing reduction strategies from 2023. This initiative reflects Avid's dedication to aligning its operations with global climate goals, particularly in the pharmaceuticals, biotechnology, and life sciences sector. While no absolute emissions figures are currently reported, Avid Bioservices' proactive stance on climate commitments positions it as a responsible player in the industry, aiming to mitigate its environmental impact and contribute to a sustainable future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Avid Bioservices is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
